In transgenic mice expressing human CRP, Grad et al. [ 61] observed that NOS and NO expressions were locally and systematically suppressed after arterial femoral injury.
These results indicate that NOS production of NO is necessary to mediate PrPC neuroprotective function.
As shown in Figure 9, L-NAME completely reversed the effect of BPA and E2, demonstrating that NOS activation and the concomitant NO increase are involved in the rapid actions of EDCs and E2 in pancreatic α-cells.
Perez and Weis (2006) explored the role of NOS in cnidarian bleaching and suggested that NOS activities measured in symbiotic algae may have been a result of host-NOS contamination [11].
The fact that NOS activity is higher at implantation sites suggests that NO has a role specifically where blastocysts attach to the endometrium.
Others, however, found decreased NO production during sepsis [ 55], and, more recently, that NOS activity is diminished in mononuclear cells from sepsis patients [ 56].
Studies showed that NOS isoforms (nNOS, iNOS, and eNOS), especially eNOS, produce both NO and superoxide anions, and the latter is dismutated by superoxide dismutase (SOD) to EDHF/H2O2, which elicits hyperpolarization followed by vasodilation.
Furthermore, it was determined that NOS-dependent endogenous NO synthesis was decreased in patients with PPH, which suggests that NOS activity may be diminished in patients with PPH [ 40].
This has spurred the hypothesis that NOS is placed where it is needed for local action of NO, akin to NOX.
Experimental and clinical studies suggest that NOS inhibition influences the activation of the trigeminal vascular system and that nonselective NOS inhibition is associated to antimigraine activity [40, 41].
However, Heo and colleagues[ 45] have shown that NOS inhibition using L-NAME reduced lipopolysaccharide-induced NO and VEGF production in human aortic smooth muscle cells.
